PHOSPHOLIPIDS AND PHOSPHOLIPID METABOLITES FOR THE TREATMENT OF VIRAL AND BACTERIAL LUNG INFLAMMATION AND SEPSIS

摘要

The invention relates to the use of acylglycerophospholipids, in particular acylglycerophosphatidylcholines and their metabolites such as lysophosphatidylcholines and alpha-glycerophosphocholines, for the treatment, for the prevention or for the support of the treatment and for the after-treatment of viral and bacterial pneumonia and sepsis, including pneumonia as a result of influenza, Covid-19, ARDS, cancer and pneumonitis after cancer immunotherapy.